Recommendation to include methyldibromo glutaronitrile in the European standard patch test series [PDF]
M. Bruze +2 more
openalex +1 more source
The IFNγ‐CIITA‐MHC II axis modulates melanoma cell susceptibility to NK‐cell‐mediated cytotoxicity
Natural killer (NK) cells play a central role in anti‐melanoma immunity. However, melanoma cells adapt during co‐culture by upregulating CIITA and MHC II in response to interferon gamma (IFNγ), thereby evading NK‐cell lysis. Blocking IFNγ signaling or treatment with dimethyl fumarate/simvastatin counteracts this immune escape and maintains NK‐cell ...
Lena C. M. Krause +6 more
wiley +1 more source
Clinical Characteristics and Patch Test Results in 57 Patients with Contact Dermatitis in Southern Taiwan. [PDF]
Lin SH, Chao YC.
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Type I hypersensitivity in photoallergic contact dermatitis
Shawn Afvari, BS +1 more
doaj +1 more source
Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023. [PDF]
Pesqué D +29 more
europepmc +1 more source
Clinical relevance of positive patch test reactions to lanolin: A ROAT study. [PDF]
Uldahl A, Engfeldt M, Svedman C.
europepmc +1 more source
Standardizing the interpretation of atopy patch testing to food in children [PDF]
Ralf G. Heine +5 more
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
Negative patch test findings after initiation of upadacitinib: A case report. [PDF]
McPhie ML, Pratt MD, Kirchhof MG.
europepmc +1 more source

